Literature DB >> 18449525

The proposed terminology 'A(1c)-derived average glucose' is inherently imprecise and should not be adopted.

Z T Bloomgarden1, S E Inzucchi, E Karnieli, D Le Roith.   

Abstract

The proposed use of a more precise standard for glycated (A(1c)) and non-glycated haemoglobin would lead to an A(1c) value, when expressed as a percentage, that is lower than that currently in use. One approach advocated to address the potential confusion that would ensue is to replace 'HbA(1c)' with a new term, 'A(1c)-derived average glucose.' We review evidence from several sources suggesting that A(1c) is, in fact, inherently imprecise as a measure of average glucose, so that the proposed terminology should not be adopted.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18449525     DOI: 10.1007/s00125-008-1027-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  29 in total

1.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

Authors:  David M Nathan; Patricia A Cleary; Jye-Yu C Backlund; Saul M Genuth; John M Lachin; Trevor J Orchard; Philip Raskin; Bernard Zinman
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

2.  Non-glycemic-dependent reduction of late pregnancy A1C levels in women with type 1 diabetes.

Authors:  Lucrecia Herranz; Lourdes Saez-de-Ibarra; Cristina Grande; Luis F Pallardo
Journal:  Diabetes Care       Date:  2007-03-15       Impact factor: 19.112

3.  A1C: does one size fit all?

Authors:  Robert M Cohen
Journal:  Diabetes Care       Date:  2007-10       Impact factor: 19.112

4.  Recommendation for term and measurement unit for "HbA1c".

Authors:  Gunnar Nordin; René Dybkaer
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

5.  High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control.

Authors:  James M Hempe; Ricardo Gomez; Robert J McCarter; Stuart A Chalew
Journal:  J Diabetes Complications       Date:  2002 Sep-Oct       Impact factor: 2.852

6.  Consensus statement on the worldwide standardization of the hemoglobin A1C measurement: the American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, and the International Diabetes Federation.

Authors: 
Journal:  Diabetes Care       Date:  2007-09       Impact factor: 19.112

7.  Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program.

Authors:  William H Herman; Yong Ma; Gabriel Uwaifo; Steven Haffner; Steven E Kahn; Edward S Horton; John M Lachin; Maria G Montez; Tina Brenneman; Elizabeth Barrett-Connor
Journal:  Diabetes Care       Date:  2007-05-29       Impact factor: 19.112

8.  Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration.

Authors:  Mark A Virtue; Julie K Furne; Frank Q Nuttall; Michael D Levitt
Journal:  Diabetes Care       Date:  2004-04       Impact factor: 19.112

9.  Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high-frequency glucose determinations by sensors.

Authors:  Darrell M Wilson
Journal:  Diabetes Care       Date:  2007-12-04       Impact factor: 19.112

10.  Relationship between glycated haemoglobin levels and mean glucose levels over time.

Authors:  D M Nathan; H Turgeon; S Regan
Journal:  Diabetologia       Date:  2007-09-13       Impact factor: 10.122

View more
  15 in total

1.  The proposed terminology 'A1c-derived average glucose' is inherently imprecise and should not be adopted. Reply to Bloomgarden ZT, Inzucchi SE, Karnieli E, et al.

Authors:  S B Haugaard; S Madsbad; J Mølvig
Journal:  Diabetologia       Date:  2008-12-09       Impact factor: 10.122

Review 2.  Prediabetes diagnosis and treatment: A review.

Authors:  Nidhi Bansal
Journal:  World J Diabetes       Date:  2015-03-15

3.  Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c.

Authors:  Kasia J Lipska; Nathalie De Rekeneire; Peter H Van Ness; Karen C Johnson; Alka Kanaya; Annemarie Koster; Elsa S Strotmeyer; Bret H Goodpaster; Tamara Harris; Thomas M Gill; Silvio E Inzucchi
Journal:  J Clin Endocrinol Metab       Date:  2010-09-22       Impact factor: 5.958

4.  Glycated haemoglobin in diabetic women with and without HIV infection: data from the Women's Interagency HIV Study.

Authors:  Marshall J Glesby; Donald R Hoover; Qiuhu Shi; Ann Danoff; Andrea Howard; Phyllis Tien; Dan Merenstein; Mardge Cohen; Elizabeth Golub; Jack Dehovitz; Marek Nowicki; Kathryn Anastos
Journal:  Antivir Ther       Date:  2010

5.  Estimated average glucose and self-monitored mean blood glucose are discordant estimates of glycemic control.

Authors:  James M Hempe; Arlette A Soros; Stuart A Chalew
Journal:  Diabetes Care       Date:  2010-03-31       Impact factor: 17.152

6.  GLYCATED ALBUMIN AT 4 WEEKS CORRELATES WITH A1C LEVELS AT 12 WEEKS AND REFLECTS SHORT-TERM GLUCOSE FLUCTUATIONS.

Authors:  Cyrus V Desouza; Julio Rosenstock; Rong Zhou; Richard G Holcomb; Vivian A Fonseca
Journal:  Endocr Pract       Date:  2015-07-27       Impact factor: 3.443

7.  Hemoglobin A1c can identify more cardiovascular and metabolic risk profile in OGTT-negative Chinese population.

Authors:  Guicheng Peng; Maohuan Lin; Kun Zhang; Jie Chen; Yifang Wang; Yu Yang; Jingfeng Wang; Hui Huang
Journal:  Int J Med Sci       Date:  2013-06-19       Impact factor: 3.738

8.  American College Of Endocrinology Pre-Diabetes Consensus Conference: part one.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2008-10       Impact factor: 17.152

Review 9.  Measurement of hemoglobin A(1c): a new twist on the path to harmony.

Authors:  David B Sacks
Journal:  Diabetes Care       Date:  2012-12       Impact factor: 19.112

10.  Approaches to treatment of type 2 diabetes.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2008-08       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.